Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Burlina

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Nutrients|July 18, 2020
The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with PhenylketonuriaAlessandro P Burlina, Chiara Cazzorla, Pamela Massa, et al.
Biochimica Et Biophysica Acta|October 18, 2002
Increased dopamine peroxidation in postmortem Parkinsonian brainAngela De Iuliis, Alessandro P Burlina, Roberta Boschetto, et al.
Magnetic Resonance in Medicine|August 1, 1995
In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classificationG Hagberg, A P Burlina, I Mader, et al.
Clinical Biochemistry|April 26, 2011
Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patientsLuca Massaccesi, Alberto Burlina, Claudia J Baquero, et al.
Neurology|September 12, 2001
Treatable neurotransmitter deficiency in mild phenylketonuriaL Bonafé, N Blau, A P Burlina, et al.
Journal of Inherited Metabolic Disease|July 15, 2000
Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatmentA B Burlina, L Bonafé, V Ferrari, et al.
Molecular Genetics and Metabolism|September 16, 2018
Malignant brain tumors in patients with glutaric aciduria type IA Serrano Russi, S Donoghue, A Boneh, et al.
Neuropediatrics|August 26, 2004
Follow-up of a child with hypoacetylaspartiaE Boltshauser, B Schmitt, R A Wevers, et al.
Advances in Experimental Medicine and Biology|June 29, 2006
Hypoacetylaspartia: clinical and biochemical follow-up of a patientAlessandro P Burlina, B Schmitt, U Engelke, et al.
Advances in Experimental Medicine and Biology|June 29, 2006
N-acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher diseaseAlessandro P Burlina, Vanni Ferrari, Alberto B Burlina, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Nutrients|July 18, 2020
The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with PhenylketonuriaAlessandro P Burlina, Chiara Cazzorla, Pamela Massa, et al.
Biochimica Et Biophysica Acta|October 18, 2002
Increased dopamine peroxidation in postmortem Parkinsonian brainAngela De Iuliis, Alessandro P Burlina, Roberta Boschetto, et al.
Magnetic Resonance in Medicine|August 1, 1995
In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classificationG Hagberg, A P Burlina, I Mader, et al.
Clinical Biochemistry|April 26, 2011
Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patientsLuca Massaccesi, Alberto Burlina, Claudia J Baquero, et al.
Neurology|September 12, 2001
Treatable neurotransmitter deficiency in mild phenylketonuriaL Bonafé, N Blau, A P Burlina, et al.
Journal of Inherited Metabolic Disease|July 15, 2000
Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatmentA B Burlina, L Bonafé, V Ferrari, et al.
Molecular Genetics and Metabolism|September 16, 2018
Malignant brain tumors in patients with glutaric aciduria type IA Serrano Russi, S Donoghue, A Boneh, et al.
Neuropediatrics|August 26, 2004
Follow-up of a child with hypoacetylaspartiaE Boltshauser, B Schmitt, R A Wevers, et al.
Advances in Experimental Medicine and Biology|June 29, 2006
Hypoacetylaspartia: clinical and biochemical follow-up of a patientAlessandro P Burlina, B Schmitt, U Engelke, et al.
Advances in Experimental Medicine and Biology|June 29, 2006
N-acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher diseaseAlessandro P Burlina, Vanni Ferrari, Alberto B Burlina, et al.
Pageof 10